My research centers on drug development at the interface of medicinal chemistry and natural products chemistry. I mostly focus on transforming bioactive natural products with promising in vitro profiles into useful drug candidates. Main areas of interest are antineoplastic and antimicrobial drugs. We use organic synthesis as a toolbox to prepare diverse analogs of natural products to obtain structure–activity relationships to further enhance the therapeutic potential of natural lead molecule. My work to date has explored several compound classes, including phenazines, lichen based usnic acid derivatives, the marine biopolymer chitosan, and steroidal scaffolds.